Breaks Categories: Stock Spotlights

ThursdayDec 23, 2021 1:03 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Building World-Class House of Brands

Flora Growth Corp. (NASDAQ: FLGC) recently signed a licensing agreement with Tonino Lamborghini that marked Flora Growth’s entry into the cannabis beverages market. Under the terms of the partnership, FLGC will produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia. The product line, which will be produced in Florida for initial sale in U.S. states where cannabidiol (“CBD”) ingestibles are legal, will contain CBD and other premium cannabinoids, including cannabigerol (“CBG”). Tonino Lamborghini is a luxury brand operating in the high-end designer products, hotel, beverage and real estate segments. “We are excited to partner with such a…

Continue Reading

ThursdayDec 23, 2021 12:34 pm

NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Expanding Reach into New Regions, Leveraging Partnerships to Facilitate Growth

Marijuana Company of America (OTC: MCOA) has taken steps to extend its reach into new regions, including Latin America, and to leverage current strategic partnerships with several companies and its wholly owned subsidiaries to facilitate growth in an industry that continues to expand despite recent setbacks. Much like other industries around the world, the marijuana market was significantly impacted by the COVID-19 pandemic. The global cannabis market, which was valued at $22.1 billion in 2020, is expected to grow at a CAGR of 13.9% during the 2021 to 2026 forecast period. Companies that MCOA has partnered with include Cannabis Global…

Continue Reading

ThursdayDec 23, 2021 12:13 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Reinventing How Insurance Is Offered, Transforming Overall Industry

FingerMotion (OTCQX: FNGR), a communications and big data technology platform builder, is expanding reinsurance industry opportunities for its Sapientus data analysis platform. The company recently announced that its subsidiary Shanghai JiuGe Information Technology Co. Ltd. inked a collaborative alliance with Munich Re, a global reinsurance powerhouse, to improve understanding of morbidity and behavioral patterns in China’s marketplace, focusing on life and health insurance. According to FingerMotion CEO Martin Shen, who is quoted in a recent article, the news “sets the stage for a longer-term strategic mission to reinvent the way we provide insurance to customers in the future and transform…

Continue Reading

ThursdayDec 23, 2021 11:48 am

NetworkNewsBreaks – DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) Portfolio Helping to Unlock Potential of Disruptive Technologies

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, has over the past six months built a portfolio of powerful partnerships, all designed to support its strategic global efforts to unlock the potential of disruptive technologies by providing advanced financial, predictive and cryptocurrency solutions across various verticals. In November, DigiMax announced a partnership with BearClaw Esports to give BearClaw’s community of streaming gamers and Esports followers access to DIGI’s CryptoHawk AI products and information. Prior to its BearClaw announcement, DigiMax partnered with Singapore-based Bitget, a crypto exchange, in an agreement that calls for…

Continue Reading

ThursdayDec 23, 2021 11:36 am

NetworkNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Witnessing Growth in Critical Key Performance Indicators

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) recently announced the addition of three new operators to its platform, bringing the total to 26. Playgon also reported that critical key performance indicators were up for November, including 12% growth in player wagering, a 28% increase in monthly active player numbers and 22% growth in bet spots. A recent article quotes company CEO Darcy Krogh as saying, “We continue to garner strong interest and onboard operators rapidly as the demand for our products continues to grow at a healthy pace… For the second month in a row, we are delivering record…

Continue Reading

WednesdayDec 22, 2021 12:49 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Lauded for Impressive Expertise Across Multiple Sectors

SRAX (NASDAQ: SRAX) is a diversified financial technology, digital marketing and consumer data management company that provides an array of consumer data to its clients, valuable to marketing and communications. Its flagship offering is a premier investor intelligence and communications platform branded Sequire. SRAX also recently launched an IR Website Builder, SMS feature and VIRA, and an IR chatbot, expanding its offering and translating to a strong increase in revenue. “SRAX’s technology unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and…

Continue Reading

WednesdayDec 22, 2021 12:38 pm

NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Committed to Creating World’s Largest Rapid Testing Network in Pharmacy

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a point-of-care health testing technology innovator, has rolled out its trademarked HealthTab(TM) platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies. The company continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function. Already, Avricore has agreements with Abbott Laboratories currently in the pilot stage that allow for the testing of markers related to conditions such as diabetes, heart disease and viruses such as SARS-CoV-2, RSV, influenza A and B, and strep, empowering patients who want to take a greater role in managing…

Continue Reading

TuesdayDec 21, 2021 2:50 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pursuing Regulatory Approvals for DehydraTECH(TM), Entry into Different Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study…

Continue Reading

MondayDec 20, 2021 2:20 pm

NetworkNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Standing Distinct in Advancing Psychedelic Medicine

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) recently released financials and a business update for the third quarter ending Sept. 30, 2021. During this reporting period, the company filed three patent applications; successfully synthesized a novel psilocin analogue with improved pharmaceutical properties; launched Mindleap 2.0, an updated version of its proprietary virtual health platform; and completed its spin-out transaction of ALT House Cannabis Inc. “The highlight of this quarter was the five-year research agreement Mydecine Innovations entered with Johns Hopkins University School of Medicine… The agreement gives the company’s medical and scientific research teams the resources needed to explore things…

Continue Reading

MondayDec 20, 2021 1:59 pm

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Advancing Core Research, Commercial Production Programs, Identifying Pipeline Expansion Opportunities

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently provided an update sharing significant milestones reached in 2021 for both of its operating arms, MINDCURE Research and MINDCURE Technology. MINDCURE Research offered several updates, including important milestones in its synthetic ibogaine manufacturing; the company is currently on schedule to provide Good Laboratory Practice (“GLP”) ibogaine to its research partners by the second quarter of 2022. In addition, a pre-clinical update from MINDCURE confirms that it intends to send ibogaine material to its pre-clinical research partner. Initially, the product will be…

Continue Reading